Companies › Eli Lilly › Total assets

Eli Lilly total assets, 2008–2025

Eli Lilly reported total assets of $112.5 billion at the end of the fiscal year ended Dec. 31, 2025, up 42.9% from $78.7 billion the year before, according to its Form 10-K.

$112.5Blatest fiscal year (ended Dec. 31, 2025)
+42.9%change from the year before
$112.5Bhighest year shown (2025)
2008: $29.2B ’08 2009: $27.5B 2010: $31.0B ’10 2011: $33.7B 2012: $34.4B ’12 2013: $35.2B 2014: $36.3B ’14 2015: $35.6B 2016: $38.8B ’16 2017: $45.0B 2018: $43.9B ’18 2019: $39.3B 2020: $46.6B ’20 2021: $48.8B 2022: $49.5B ’22 2023: $64.0B 2024: $78.7B ’24 2025: $112.5B ’25

Fiscal years labeled by the year in which they ended. Bars drawn from the table below.

Eli Lilly total assets by fiscal year

Fiscal year endedTotal assetsChangeFiling
Dec. 31, 2025 $112.5B +42.9% 10-K (2026) ↗
Dec. 31, 2024 $78.7B +23.0% 10-K (2026) ↗
Dec. 31, 2023 $64.0B +29.3% 10-K (2025) ↗
Dec. 31, 2022 $49.5B +1.4% 10-K (2024) ↗
Dec. 31, 2021 $48.8B +4.7% 10-K (2023) ↗
Dec. 31, 2020 $46.6B +18.7% 10-K (2022) ↗
Dec. 31, 2019 $39.3B −10.5% 10-K (2021) ↗
Dec. 31, 2018 $43.9B −2.4% 10-K (2020) ↗
Dec. 31, 2017 $45.0B +15.9% 10-K (2019) ↗
Dec. 31, 2016 $38.8B +9.1% 10-K (2018) ↗
Dec. 31, 2015 $35.6B −2.0% 10-K (2017) ↗
Dec. 31, 2014 $36.3B +3.0% 10-K (2016) ↗
Dec. 31, 2013 $35.2B +2.5% 10-K (2015) ↗
Dec. 31, 2012 $34.4B +2.2% 10-K (2014) ↗
Dec. 31, 2011 $33.7B +8.6% 10-K (2013) ↗
Dec. 31, 2010 $31.0B +12.9% 10-K (2012) ↗
Dec. 31, 2009 $27.5B −6.0% 10-K (2011) ↗
Dec. 31, 2008 $29.2B — 10-K (2010) ↗

Other Eli Lilly financials

RevenueNet incomeDiluted EPSR&D expenseOperating cash flowDividends per shareDiluted sharesCash and equivalentsStockholders' equity Quarterly results and next earnings date Eli Lilly company hub

FAQ

Q What was Eli Lilly's total assets in its latest fiscal year?

A Eli Lilly reported total assets of $112.5 billion at the end of the fiscal year ended Dec. 31, 2025, up 42.9% from $78.7 billion the year before, according to its Form 10-K.

Q What is Eli Lilly's highest annual total assets on record here?

A $112.5 billion, in the fiscal year ended Dec. 31, 2025, among the fiscal years 2008–2025 reported in its 10-K XBRL data.

Q Where does this total assets data come from?

A From Eli Lilly's annual reports on Form 10-K, as tagged in XBRL and published by the SEC (company facts). Total assets on the balance sheet at fiscal year-end.

Source: Eli Lilly's annual reports on Form 10-K via SEC XBRL company facts, updated Oct. 15, 2026. Total assets on the balance sheet at fiscal year-end. For each year the most recent 10-K that reports it is used, so a figure a company later restated shows the restated value; the filing link shows which report it came from. Change is our arithmetic. Financial data, not investment advice.